Ketoconazole therapy and exfoliative erythroderma.
D002177:Candidiasis / Q000517:prevention & control; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D006084:Graft Rejection; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007654:Ketoconazole; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*
D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole